{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MAPK", "PI3K/mTOR", "STAT3", "c-MET", "leukemia", "sanguinarine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37175820", "DateCompleted": {"Year": "2023", "Month": "05", "Day": "15"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "30"}], "Language": ["eng"], "ELocationID": ["8113", "10.3390/ijms24098113"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "9", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "30"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling.", "Abstract": {"AbstractText": ["Sanguinarine (<b>1</b>) is a natural product with significant pharmacological effects. However, the application of sanguinarine has been limited due to its toxic side effects and a lack of clarity regarding its molecular mechanisms. To reduce the toxic side effects of sanguinarine, its cyanide derivative (<b>1a</b>) was first designed and synthesized in our previous research. In this study, we confirmed that <b>1a</b> presents lower toxicity than sanguinarine but shows comparable anti-leukemia activity. Further biological studies using RNA-seq, lentiviral transfection, Western blotting, and flow cytometry analysis first revealed that both compounds <b>1</b> and <b>1a</b> inhibited the proliferation and induced the apoptosis of leukemic cells by regulating the transcription of c-MET and then suppressing downstream pathways, including the MAPK, PI3K/AKT and JAK/STAT pathways. Collectively, the data indicate that <b>1a</b>, as a potential anti-leukemia lead compound regulating c-MET transcription, exhibits better safety than <b>1</b> while maintaining cytostatic activity through the same mechanism as <b>1</b>."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Xu", "ForeName": "Xinglian", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Deng", "ForeName": "Lulu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Kunming Institute of Botany, Chinese Academy of Sciences (CAS), Kunming 650201, China."}], "LastName": "Tang", "ForeName": "Yaling", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Li", "ForeName": "Jiang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Zhong", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Kunming Institute of Botany, Chinese Academy of Sciences (CAS), Kunming 650201, China."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Fan", "ForeName": "Yanhua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Beijin Road, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Beijin Road, Guiyang 550014, China."}], "LastName": "Mu", "ForeName": "Shuzhen", "Initials": "S"}], "GrantList": [{"GrantID": "U1812403-3", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "22067003", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "31760097", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "(QKH Foundation-ZK (2021) General 516)", "Agency": "Science and Technology Projects of GuizhouProvince", "Country": ""}, {"GrantID": "(Qian Ke He KY (2021) 181)", "Agency": "Technological Talents in Colleges and Universities of Guizhou Province", "Country": ""}, {"GrantID": "(QKH-JC [2019]1430)", "Agency": "Science and Technology Program of Guizhou Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytostatic Agents"}, {"RegistryNumber": "AV9VK043SS", "NameOfSubstance": "sanguinarine"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyanides"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cytostatic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Cyanides"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lou G., Wang J., Hu J., Gan Q., Peng C., Xiong H., Huang Q. Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect. Anti-Cancer Agents Med. Chem. 2021;21:2100\u20132110. doi: 10.2174/1871520621666210126091512.", "ArticleIdList": ["10.2174/1871520621666210126091512", "33573577"]}, {"Citation": "Fu C., Guan G., Wang H. The Anticancer Effect of Sanguinarine: A Review. Curr. Pharm. Des. 2018;24:2760\u20132764. doi: 10.2174/1381612824666180829100601.", "ArticleIdList": ["10.2174/1381612824666180829100601", "30156147"]}, {"Citation": "Lu C., Zhang N., Kou S., Gao L., Peng B., Dai Y., Zheng J. Sanguinarine synergistically potentiates aminoglycoside-mediated bacterial killing. Microb. Biotechnol. 2022;15:2055\u20132070. doi: 10.1111/1751-7915.14017.", "ArticleIdList": ["10.1111/1751-7915.14017", "PMC9249330", "35318794"]}, {"Citation": "Jena A.B., Kanungo N., Chainy G.B.N., Devaraji V., Das S.K., Dandapat J. A Computational Insight on the Inhibitory Potential of 8-Hydroxydihydr of Sanguinarine (8-HDS), a Pyridone Containing Analog of Sanguinarine, Against SARS CoV2. Chem Biodivers. 2022;19:e202200266. doi: 10.1002/cbdv.202200266.", "ArticleIdList": ["10.1002/cbdv.202200266", "PMC9538102", "36151910"]}, {"Citation": "Niu X., Fan T., Li W., Huang H. The Anti-inflammatory Effects of Sanguinarine and Its Modulation of in Flammatory Mediators from Peritoneal Macrophages. Eur. J. Pharmacol. 2012;689:262\u2013269. doi: 10.1016/j.ejphar.2012.05.039.", "ArticleIdList": ["10.1016/j.ejphar.2012.05.039", "22705062"]}, {"Citation": "Khan A.Q., Rashid K., AlAmodi A.A., Agha M.V., Akhtar S., Hakeem I., Raza S.S., Uddin S. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids. Biomed. Pharmacother. 2021;143:112142. doi: 10.1016/j.biopha.2021.112142.", "ArticleIdList": ["10.1016/j.biopha.2021.112142", "34536761"]}, {"Citation": "Wang X., Yang X., Wang J., Li L., Zhang Y., Jin M., Chen X., Sun C., Wang R., Liu K. Cardiotoxicity of sanguinarine via regulating apoptosis and MAPK pathways in zebrafish and HL1 cardiomyocytes. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2021;252:109228. doi: 10.1016/j.cbpc.2021.109228.", "ArticleIdList": ["10.1016/j.cbpc.2021.109228", "34744004"]}, {"Citation": "Singh N., Sharma B. Toxicological Effects of Berberine and Sanguinarine. Front. Mol. Biosci. 2018;5:21. doi: 10.3389/fmolb.2018.00021.", "ArticleIdList": ["10.3389/fmolb.2018.00021", "PMC5867333", "29616225"]}, {"Citation": "Tang Y., Xu X., Li J., Deng L., Mu S. Synthesis and Antileukemia Activity Evaluation of Benzophenanthridine Alkaloid Derivatives. Molecules. 2022;27:3934. doi: 10.3390/molecules27123934.", "ArticleIdList": ["10.3390/molecules27123934", "PMC9227418", "35745057"]}, {"Citation": "Laines-Hidalgo J.I., Mu\u00f1oz-S\u00e1nchez J.A., Loza-M\u00fcller L., V\u00e1zquez-Flota F. An Update of the Sanguinarine and Benzophenanthridine Alkaloids\u2019 Biosynthesis and Their Applications. Molecules. 2022;27:1378. doi: 10.3390/molecules27041378.", "ArticleIdList": ["10.3390/molecules27041378", "PMC8876366", "35209167"]}, {"Citation": "Yu C., Li P., Wang Y.-X., Zhang K.-G., Zheng Z.-C., Liang L.-S. Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model. Drug Des. Dev. Ther. 2020;14:4725\u20134733. doi: 10.2147/DDDT.S276424.", "ArticleIdList": ["10.2147/DDDT.S276424", "PMC7649226", "33177809"]}, {"Citation": "Zhang S., Leng T., Zhang Q., Nie X., Yang L. Sanguinarine Inhibits Epithelial Ovarian Cancer Development via Regulating Long Non-coding RNA CASC2-EIF4A3 Axis and/or Inhibiting NF-\u03baB Signaling or PI3K/AKT/mTOR Pathway. Biomed. Pharmacother. 2018;102:302\u2013308. doi: 10.1016/j.biopha.2018.03.071.", "ArticleIdList": ["10.1016/j.biopha.2018.03.071", "29571014"]}, {"Citation": "Akhtar S., Achkar I.W., Siveen K.S., Khan A.Q., Ahmed E.I., Sahir F., Jerobin J., Raza A., Merhi M., Elsabah H.M., et al. Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JAK2/STAT3 Signaling. Front Oncol. 2019;9:285. doi: 10.3389/fonc.2019.00285.", "ArticleIdList": ["10.3389/fonc.2019.00285", "PMC6478801", "31058086"]}, {"Citation": "Zhang B., Wang X., Deng J., Zheng H., Liu W., Chen S., Tian J., Wang F. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Lett. 2019;459:50\u201358. doi: 10.1016/j.canlet.2019.05.042.", "ArticleIdList": ["10.1016/j.canlet.2019.05.042", "31163195"]}, {"Citation": "Zhao Y., Ye W., Wang Y.-D., Chen W.-D. HGF/c-Met: A Key Promoter in Liver Regeneration. Front. Pharmacol. 2022;13:808855. doi: 10.3389/fphar.2022.808855.", "ArticleIdList": ["10.3389/fphar.2022.808855", "PMC8968572", "35370682"]}, {"Citation": "Stefani C., Miricescu D., Stanescu I., Nica R.I., Greabu M., Totan A.R., Jinga M. (Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are we Now? Int. J. Mol. Sci. 2021;22:10260. doi: 10.3390/ijms221910260.", "ArticleIdList": ["10.3390/ijms221910260", "PMC8508474", "34638601"]}, {"Citation": "Blang\u00e9 D., Stroes C.I., Derks S., Bijlsma M.F., van Laarhoven H.W. Resistance Mechanisms to HER2-targeted Therapy in Aastroesophageal Adenocarcinoma: A Systematic Review. Cancer Treat. Rev. 2022;108:102418. doi: 10.1016/j.ctrv.2022.102418.", "ArticleIdList": ["10.1016/j.ctrv.2022.102418", "35689885"]}, {"Citation": "Uchikawa E., Chen Z., Xiao G.-Y., Zhang X., Bai X.-C. Structural basis of the activation of c-MET receptor. Nat. Commun. 2021;12:1\u201314. doi: 10.1038/s41467-021-24367-3.", "ArticleIdList": ["10.1038/s41467-021-24367-3", "PMC8249616", "34210960"]}, {"Citation": "Damghani T., Elyasi M., Pirhadi S., Haghighijoo Z., Ghazi S. Type II c-Met inhibitors: Molecular insight into crucial interactions for effective inhibition. Mol. Divers. 2021;26:1411\u20131423. doi: 10.1007/s11030-021-10267-7.", "ArticleIdList": ["10.1007/s11030-021-10267-7", "34247323"]}, {"Citation": "Wang H., Rao B., Lou J., Li J., Liu Z., Li A., Cui G., Ren Z., Yu Z. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Front. Cell Dev. Biol. 2020;8:55. doi: 10.3389/fcell.2020.00055.", "ArticleIdList": ["10.3389/fcell.2020.00055", "PMC7018668", "32117981"]}, {"Citation": "Ci T., Zhang W., Qiao Y., Li H., Zang J., Li H., Feng N., Gu Z. Delivery strategies in treatments of leukemia. Chem. Soc. Rev. 2022;51:2121\u20132144. doi: 10.1039/D1CS00755F.", "ArticleIdList": ["10.1039/D1CS00755F", "35188506"]}, {"Citation": "Roloff G.W., Odenike O., Bajel A., Wei A.H., Foley N., Uy G.L. Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022. Am. Soc. Clin. Oncol. Educ. Book. 2022:568\u2013583. doi: 10.1200/EDBK_349605.", "ArticleIdList": ["10.1200/EDBK_349605", "35658497"]}, {"Citation": "Cao X., Fu M., Bi R., Zheng X., Fu B., Tian S., Liu C., Li Q., Liu J. Cadmium induced BEAS-2B cells apoptosis and mitochondria damage via MAPK signaling pathway. Chemosphere. 2020;263:128346. doi: 10.1016/j.chemosphere.2020.128346.", "ArticleIdList": ["10.1016/j.chemosphere.2020.128346", "33297271"]}, {"Citation": "Feng H., Hu L., Zhu H., Tao L., Wu L., Zhao Q., Gao Y., Gong Q., Mao F., Li X., et al. Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent. Acta Pharm. Sin. B. 2019;10:434\u2013446. doi: 10.1016/j.apsb.2019.08.002.", "ArticleIdList": ["10.1016/j.apsb.2019.08.002", "PMC7049605", "32140390"]}, {"Citation": "Yang D.L., Zhang Y.J., Lei J., Li S.Q., He L.J., Tang D.Y., Xu C., Zhang L.T., Wen J., Lin H.K., et al. Discovery of Fused Benzimidazole-imidazole Autophagic Flux Inhibitors for Treatment of Triple-negative Treast Cancer. Eur. J. Med. Chem. 2022;240:114565. doi: 10.1016/j.ejmech.2022.114565.", "ArticleIdList": ["10.1016/j.ejmech.2022.114565", "35797901"]}, {"Citation": "Zaky M.Y., Liu X., Wang T., Wang S., Liu F., Wang D., Wu Y., Zhang Y., Guo D., Sun Q., et al. Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met. Arch. Biochem. Biophys. 2020;680:108239. doi: 10.1016/j.abb.2019.108239.", "ArticleIdList": ["10.1016/j.abb.2019.108239", "31881189"]}, {"Citation": "Rose M., Burgess J.T., O\u2019byrne K., Richard D.J., Bolderson E. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. Front. Cell Dev. Biol. 2020;8:564601. doi: 10.3389/fcell.2020.564601.", "ArticleIdList": ["10.3389/fcell.2020.564601", "PMC7509090", "33015058"]}, {"Citation": "Wang C., Liu H., Yang M., Bai Y., Ren H., Zou Y., Yao Z., Zhang B., Li Y. RNA-Seq Based Transcriptome Analysis of Endothelial Differentiation of Bone Marrow Mesenchymal Stem Cells. Eur. J. Vasc. Endovasc. Surg. 2019;59:834\u2013842. doi: 10.1016/j.ejvs.2019.11.003.", "ArticleIdList": ["10.1016/j.ejvs.2019.11.003", "31874808"]}, {"Citation": "Lu S., Zhu N., Guo W., Wang X., Li K., Yan J., Jiang C., Han S., Xiang H., Xiaohan W., et al. RNA-Seq revealed a circular RNA-microRNA-mRNA Regulatory Network in Hantaan Virus Infection. Front. Cell Infect. Microbiol. 2022;10:97. doi: 10.3389/fcimb.2020.00097.", "ArticleIdList": ["10.3389/fcimb.2020.00097", "PMC7083127", "32232013"]}, {"Citation": "Fang J.Y., Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322\u2013327. doi: 10.1016/S1470-2045(05)70168-6.", "ArticleIdList": ["10.1016/S1470-2045(05)70168-6", "15863380"]}, {"Citation": "Raj S., Kesari K.K., Kumar A., Rathi B., Sharma A., Gupta P.K., Jha S.K., Jha N.K., Slama P., Roychoudhury S., et al. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Mol. Cancer. 2022;21:1\u201316. doi: 10.1186/s12943-022-01503-1.", "ArticleIdList": ["10.1186/s12943-022-01503-1", "PMC8790852", "35081970"]}, {"Citation": "Besser D., Bardelli A., Didichenko S., Thelen M., Comoglio P.M., Ponzetto C., Nagamine Y. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene. 1997;14:705\u2013711. doi: 10.1038/sj.onc.1200879.", "ArticleIdList": ["10.1038/sj.onc.1200879", "9038378"]}, {"Citation": "Gao J., Inagaki Y., Song P., Qu X., Kokudo N., Tang W. Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma. Pharmacol. Res. 2012;65:23\u201330. doi: 10.1016/j.phrs.2011.11.011.", "ArticleIdList": ["10.1016/j.phrs.2011.11.011", "22138044"]}, {"Citation": "Pons E., Uphoff C., Drexler H. Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. Leuk. Res. 1998;22:797\u2013804. doi: 10.1016/S0145-2126(98)00071-X.", "ArticleIdList": ["10.1016/S0145-2126(98)00071-X", "9716011"]}, {"Citation": "Paiva R.S., Gomes I., Casimiro S., Fernandes I., Costa L. c-Met expression in renal cell carcinoma with bone metastases. J. Bone Oncol. 2020;25:100315. doi: 10.1016/j.jbo.2020.100315.", "ArticleIdList": ["10.1016/j.jbo.2020.100315", "PMC7527574", "33024658"]}, {"Citation": "Hu Y., Gong C., Li Z., Liu J., Chen Y., Huang Y., Luo Q., Wang S., Hou Y., Yang S., et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol. Cancer. 2022;21:1\u201315. doi: 10.1186/s12943-022-01522-y.", "ArticleIdList": ["10.1186/s12943-022-01522-y", "PMC8812266", "35114989"]}, {"Citation": "Sheng W., Guo W., Lu F., Liu H., Xia R., Dong F. Upregulation of Linc00284 Promotes Lung Cancer Progression by Regulating the miR-205-3p/c-Met Axis. Front. Genet. 2021;12:694571. doi: 10.3389/fgene.2021.694571.", "ArticleIdList": ["10.3389/fgene.2021.694571", "PMC8488201", "34616424"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "29"}, {"Year": "2023", "Month": "4", "Day": "18"}, {"Year": "2023", "Month": "4", "Day": "27"}, {"Year": "2023", "Month": "5", "Day": "15", "Hour": "11", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "13", "Hour": "15", "Minute": "13"}, {"Year": "2023", "Month": "5", "Day": "13", "Hour": "1", "Minute": "29"}, {"Year": "2023", "Month": "4", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["37175820", "PMC10179035", "10.3390/ijms24098113", "ijms24098113"]}}], "PubmedBookArticle": []}